Wayne State University and Oakwood Partner in New Device to Combat Congestive Hea...(ellence in Heart and Vascular Orthopedic...),Health

Date:4/7/2008

ellence in Heart and Vascular, Orthopedics/Neurology, Women's Health and Cancer. The facility is accredited by the Joint Commission and received the coveted Gold Seal of Approval in 2007 for its Total Joint Replacement program. OHMC was recognized as a "Top 100" cardiology hospital for the seventh time in eight years.

Wayne State University is a premier institution of higher education offering more than 350 academic programs to more than 33,000 students through 11 schools and colleges. For more information, visit http://www.wayne.edu. With more than 1,000 students, Wayne's School of Medicine is the nation's largest single-campus medical school. Together with the Wayne State University Physician Group and 13 hospital partners, the school is a leader in medical education, biomedical research, and patient care. Its programs of excellence include cancer, maternal-child health, neurosciences, and population studies and urban health. For more information, visit http://www.med.wayne.edu.

'/>"/>

SOURCE Oakwood Healthcare System; Wayne State University Schoolof Medicine Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
3. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
4. Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
8. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
9. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
10. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
11. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds